U.S. federal trademark · Serial No. 99031105
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.